Shanghai Aohua Photoelectricity Endoscope Co Ltd
SSE:688212
| US |
|
Fubotv Inc
NYSE:FUBO
|
Media
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
| US |
|
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
| CN |
|
NIO Inc
NYSE:NIO
|
Automobiles
|
| US |
|
Fluor Corp
NYSE:FLR
|
Construction
|
| US |
|
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
| US |
|
TopBuild Corp
NYSE:BLD
|
Consumer products
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
Health Care
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
| US |
|
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
| US |
|
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
| US |
|
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
| US |
|
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
| US |
|
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
32
67.73
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
|
|
Fubotv Inc
NYSE:FUBO
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
C
|
C3.ai Inc
NYSE:AI
|
US |
|
|
Uber Technologies Inc
NYSE:UBER
|
US |
|
|
NIO Inc
NYSE:NIO
|
CN |
|
|
Fluor Corp
NYSE:FLR
|
US |
|
|
Jacobs Engineering Group Inc
NYSE:J
|
US |
|
|
TopBuild Corp
NYSE:BLD
|
US |
|
|
Abbott Laboratories
NYSE:ABT
|
US |
|
|
Chevron Corp
NYSE:CVX
|
US |
|
|
Occidental Petroleum Corp
NYSE:OXY
|
US |
|
|
Matrix Service Co
NASDAQ:MTRX
|
US |
|
|
Automatic Data Processing Inc
NASDAQ:ADP
|
US |
|
|
Qualcomm Inc
NASDAQ:QCOM
|
US |
|
|
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Shanghai Aohua Photoelectricity Endoscope Co Ltd
Total Receivables
Shanghai Aohua Photoelectricity Endoscope Co Ltd
Total Receivables Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
S
|
Shanghai Aohua Photoelectricity Endoscope Co Ltd
SSE:688212
|
Total Receivables
¥218.4m
|
CAGR 3-Years
78%
|
CAGR 5-Years
29%
|
CAGR 10-Years
N/A
|
|
|
A
|
APT Medical Inc
SSE:688617
|
Total Receivables
¥50.5m
|
CAGR 3-Years
1%
|
CAGR 5-Years
11%
|
CAGR 10-Years
N/A
|
|
|
J
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
|
Total Receivables
¥1.4B
|
CAGR 3-Years
4%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
3%
|
|
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
Total Receivables
¥4.6B
|
CAGR 3-Years
24%
|
CAGR 5-Years
17%
|
CAGR 10-Years
N/A
|
|
|
J
|
Jafron Biomedical Co Ltd
SZSE:300529
|
Total Receivables
¥120m
|
CAGR 3-Years
-28%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
N/A
|
|
|
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
|
Total Receivables
¥3.7B
|
CAGR 3-Years
56%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Shanghai Aohua Photoelectricity Endoscope Co Ltd
Glance View
Shanghai Aohua Photoelectricity Endoscope Co., Ltd. engages in the research, development, production, and sale of endoscope products. The company is headquartered in Shanghai, Shanghai and currently employs 865 full-time employees. The company went IPO on 2021-11-15. The firm's main businesses are the research, development, production and sales of electronic endoscopic equipment and endoscopic diagnostic and surgical consumables. The firm's products include endoscopic equipment and endoscopic diagnostic and surgical consumables. The firm's products are mainly used in clinical departments such as gastroenterology, respiratory, ears, nose, and throat (ENT), gynecology, and emergency departments.
See Also
What is Shanghai Aohua Photoelectricity Endoscope Co Ltd's Total Receivables?
Total Receivables
218.4m
CNY
Based on the financial report for Dec 31, 2023, Shanghai Aohua Photoelectricity Endoscope Co Ltd's Total Receivables amounts to 218.4m CNY.
What is Shanghai Aohua Photoelectricity Endoscope Co Ltd's Total Receivables growth rate?
Total Receivables CAGR 5Y
29%
Over the last year, the Total Receivables growth was 41%. The average annual Total Receivables growth rates for Shanghai Aohua Photoelectricity Endoscope Co Ltd have been 78% over the past three years , 29% over the past five years .
You don't have any saved screeners yet
